Net Income (Quarterly) Chart

View Net Income (Quarterly) for HLSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.846M
March 31, 2026 -19.14M
December 31, 2025 -13.34M
September 30, 2025 -9.166M
June 30, 2025 -6.037M
March 31, 2025 -7.659M
December 31, 2024 -14.51M
September 30, 2024 5.067M
June 30, 2024 0.955M
March 31, 2024 -17.33M
December 31, 2023 -5.491M
September 30, 2023 -7.906M
June 30, 2023 -6.411M
March 31, 2023 -6.361M
December 31, 2022 -5.886M
September 30, 2022 -6.78M
Date Value
June 30, 2022 -7.482M
March 31, 2022 -8.169M
December 31, 2021 -10.46M
September 30, 2021 -10.03M
June 30, 2021 -7.336M
March 31, 2021 -8.402M
December 31, 2020 -9.144M
September 30, 2020 -8.835M
June 30, 2020 -6.206M
March 31, 2020 -5.901M
December 31, 2019 -9.30M
September 30, 2019 -4.26M
June 30, 2019 -6.960M
March 31, 2019 -4.408M
December 31, 2018 -4.137M
September 30, 2018 -3.205M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.567M
Amgen, Inc. 2.375B
Anika Therapeutics, Inc. 3.309M
BioCryst Pharmaceuticals, Inc. 78.40M
Imunon, Inc. -2.814M